Effects of long-term administration of intranasal oxytocin in children with autism spectrum disorder
Not Applicable
- Conditions
- Autism spectrum disorder
- Registration Number
- JPRN-UMIN000017876
- Lead Sponsor
- nited Graduate School of Child Development, Osaka University
- Brief Summary
Only one child was recruited with any apparent adverse events. It was impossible to analyze the therapeutic effectiveness from one case. This study was discontinued because of the sudden unavailability of the researchers involved in this study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 1
Inclusion Criteria
Not provided
Exclusion Criteria
1. Comorbid cardiovascular disease or renal disease 2. History of allergy to oxytocin 3. Female 4. Patients who has used the intranasal oxytocin in the past 5. Responsible doctors judged the trial inappropriate for the patient.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SRS total score Adverse events Blood pressure,body weight Serum Na concentration, serum osmolality
- Secondary Outcome Measures
Name Time Method Global Assessment of Functioning (GAF) SRS subscale scores CBCL total score, externalizing score, internalizing score, subscale scores. ABC-J subscale scores